Logo

Procter & Gamble Health Share Price

NSE: PGHL
|
Pharmaceuticals
₹ 6,355.00
-₹108.00 (-1.67%)
1D
Last updated 03 Jul, 2026, 15:29 IST

Procter & Gamble Health Share Price Today

As of 5 Jul 2026, Procter & Gamble Health share price is ₹6,355.00. The stock opened at ₹6,499.50, compared to its previous close of ₹6,463.00. During today's trading session, Procter & Gamble Health share price moved in the range of ₹6,333.00 to ₹6,525.00, with an average price of ₹6,429.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,707.00 and a high of ₹6,739.00. On the performance front, Procter & Gamble Health share price has increased by 11.36% over the last six months and is up 8.46% on a year-on-year basis.

₹6,333.00
1.67% down today
₹6,525.00
1D LOW
1D HIGH

Procter & Gamble Health Returns Calculator

Open
₹6,499.50
High
₹6,525.00
Low
₹6,333.00
Prev. close
₹6,463.00
Circuit
L
H
₹5,079.50
₹7,618.50
52-week
L
H
₹4,707.00
₹6,739.00

Procter & Gamble Health Shareholder Returns

Procter & Gamble Health Share Price History

Mkt Cap Cr
10,725.30
P/E
32.81
P/B
20.45
ROE
62.32%
D/E
0.02
ROCE
84.14%
Div. Yield
6.42%
EPS(TTM)
196.94
Turnover
2.40
EV/EBITDA
21.85
Net Margin
0.00%
Op. Margin
0.00%
ROA
38.86%
Quick Ratio
0.00
Curr. Ratio
2.21
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
P & G Health Ltd outperforming all market indices
Step 1 of 5
Valuation
Overvalued
P & G Health Ltd appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Procter & Gamble Health Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Revenue₹934.17₹1,151.26₹1,229.62₹1,114.41
Other Income₹10.35₹15.63₹18.39₹13.19
Total Revenue₹944.52₹1,166.89₹1,248.01₹1,127.60
Total Expenses₹632.90₹873.38₹933.81₹874.23
Profit Before Tax₹311.62₹273.32₹314.20₹253.37
Tax₹77.21₹72.34₹84.73₹60.85
Profit After Tax₹234.41₹200.98₹229.47₹192.52
EPS - Basic₹141.00₹121.00₹138.00₹116.00
EPS - Diluted₹141.00₹121.00₹138.00₹116.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Profit before tax₹311.62₹273.32₹314.20₹253.37
Income before WC changes₹323.82₹325.59₹355.69₹280.68
Change in Assets-₹69.92₹70.57-₹97.15-₹49.18
Change in Liabilities-₹3.89-₹82.68₹67.13₹1.88
Change in WC-₹73.81-₹12.11-₹30.02-₹47.30
Cash flow from Operations₹168.69₹228.29₹236.01₹169.52
Cash flow from Investing₹9.59-₹6.87-₹21.50-₹25.54
Cash flow from Financing-₹234.74-₹418.11-₹98.49-₹288.63
Total Cash Flow-₹56.46-₹196.69₹116.02-₹144.65
Cash (Start of the year)₹238.73₹435.42₹319.40₹464.05
Cash (End of the year)₹182.27₹238.73₹435.42₹319.40

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Non-Current Assets₹267.81₹270.14₹305.09₹280.08
Current Assets₹526.39₹524.22₹796.10₹608.04
Total Assets₹794.20₹794.36₹1,101.19₹888.12
Current Liabilities₹215.31₹218.91₹303.90₹231.90
Net Current Asset₹311.08₹305.31₹492.20₹376.14
Non-Current Liabilities₹41.93₹37.21₹46.40₹39.73
Equity Capital₹536.96₹538.24₹750.89₹616.49
Total Equity & Liabilities₹794.20₹794.36₹1,101.19₹888.12
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
6349
2
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
63.08
Neutral
ATR (14)
126.68
Neutral
STOCH(9,6)
48.99
Neutral
STOCH RSI (14)
9.59
Bullish
ADX(9)
68.83
Bearish
UO(9)
44.01
Neutral
ROC(12)
1.97
Bullish
WillR(14)
-50.79
Neutral
Period
Simple value
Exponential vaue
5D
6345.9
6350.75
10D
6296.25
6311.09
20D
6265.83
6212.24
50D
5779.17
5885.78
100D
5383.48
5667.5

About Procter & Gamble Health

Procter & Gamble Health logo
ISIN
INE199A01012
Sector Market Cap
₹ 10,725.3 Cr

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.

Know more
Promoters
51.82%
FII
6.20%
Other DII
3.47%
Retail and other
28.31%
Mutual funds
10.20%
Foreign institutions - FII
Compare against other stocks
Procter & Gamble Health logo
Procter & Gamble Health
Pharmaceuticals
Add Stock
Add Another

FAQs on Procter & Gamble Health Share Price